Dachaigh › Galar Ae Steatotic › Virginia
Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an Virginia
Tha 14 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann an Virginia.
Bailtean ann an Virginia
Teacsa sgrùdaidh oifigeil (Beurla)
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Virginia Commonwealth University, Richmond
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05832229A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- University of Virginia Medical Center, Charlottesville
- Richmond Veterans Administration Medical Center, Richmond
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Eximia Research - Norfolk, Norfolk
- Richmond Veterans Affairs Medical Center (Richmond VA Medical Center), Richmond
- Virginia Commonwealth University (VCU) Medical Center, Richmond
- agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Norfolk
- Akero Clinical Study Site, Richmond
- Akero Clinical Study Site, Richmond
- agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Manassas
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GI Alliance Richmond, Richmond
- GI Select Health Research, Richmond
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06419374A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Richmond
- GSK Investigational Site, Richmond
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Manassas
- GSK Investigational Site, Norfolk
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Richmond
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06920043Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- Virginia Commonwealth University, Richmond
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT05424003Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- University of Virginia, Charlottesville
- Virginia Common wealth University, Richmond
A’ fastadh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04054310Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
- Virginia Commonwealth University, Richmond
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Gibl 2026 · NCT05720663Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.